The reason why cancer cells are resistant to TRAIL-induced apoptosis is not yet known, but many clinical studies have attributed TRAIL-resistance to the down-regulation of TRAIL receptors [5] and to mutation of caspase-8 [6]. This evidence concerns the gene CASP8 and cancer.